Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Extracellular vesicle PD-L1 in reshaping tumor immune microenvironment: biological function and potential therapy strategies
Jiaxing Liu, Xueqiang Peng, Shuo Yang, et al.
Cell Communication and Signaling (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Tumor microenvironment signaling and therapeutics in cancer progression
Anshika Goenka, Fatima Khan, Bhupender Verma, et al.
Cancer Communications (2023) Vol. 43, Iss. 5, pp. 525-561
Open Access | Times Cited: 117
Radiation-induced PD-L1 expression in tumor and its microenvironment facilitates cancer-immune escape: a narrative review
Nuo-Han Wang, Zheng Lei, Hao-Nan Yang, et al.
Annals of Translational Medicine (2022) Vol. 10, Iss. 24, pp. 1406-1406
Open Access | Times Cited: 44
Tumor-derived exosomes in the cancer immune microenvironment and cancer immunotherapy
Qiushi Tang, Shuo Yang, Guangpeng He, et al.
Cancer Letters (2022) Vol. 548, pp. 215823-215823
Closed Access | Times Cited: 43
Extracellular vesicles as next generation immunotherapeutics
David W. Greening, Rong Xu, Anukreity Ale, et al.
Seminars in Cancer Biology (2023) Vol. 90, pp. 73-100
Closed Access | Times Cited: 39
Engineered EVs designed to target diseases of the CNS
Lisa Nieland, Shadi Mahjoum, Emily Grandell, et al.
Journal of Controlled Release (2023) Vol. 356, pp. 493-506
Open Access | Times Cited: 39
Targeting MYC at the intersection between cancer metabolism and oncoimmunology
Simran Venkatraman, Brinda Balasubramanian, Chanitra Thuwajit, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 11
The Role of Extracellular Vesicles in Metabolic Reprogramming of the Tumor Microenvironment
Eran Fridman, Lana Ginini, Ziv Gil
Cells (2022) Vol. 11, Iss. 9, pp. 1433-1433
Open Access | Times Cited: 35
Exosomes Derived from Immune Cells: The New Role of Tumor Immune Microenvironment and Tumor Therapy
Shiyang Wang, Yue Shi
International Journal of Nanomedicine (2022) Vol. Volume 17, pp. 6527-6550
Open Access | Times Cited: 30
Hypoxia-Driven Changes in Tumor Microenvironment: Insights into Exosome-Mediated Cell Interactions
Churan Wang, Shun Xu, Xiao Yang
International Journal of Nanomedicine (2024) Vol. Volume 19, pp. 8211-8236
Open Access | Times Cited: 6
Extracellular vesicle-cell adhesion molecules in tumours: biofunctions and clinical applications
Weikai Lin, Jianjun Fang, Shibo Wei, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 14
Exosome-derived microRNAs: emerging players in vitiligo
Wenquan li, Yaobin Pang, Qingying He, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 5
PKCα regulates the secretion of PDL1-carrying small extracellular vesicles in a p53-dependent manner
Ren Zhang, Weilin Liao, Xi Chen, et al.
Cell Death and Disease (2025) Vol. 16, Iss. 1
Open Access
Cellular nanovesicles for therapeutic immunomodulation: A perspective on engineering strategies and new advances
Endong Zhang, Philana Phan, Zongmin Zhao
Acta Pharmaceutica Sinica B (2022) Vol. 13, Iss. 5, pp. 1789-1827
Open Access | Times Cited: 21
Research progress on mitochondria regulating tumor immunity
Jing Li, Pinglong Xu, Shasha Chen
Journal of Zhejiang University (Medical Sciences) (2024) Vol. 53, Iss. 1, pp. 1-14
Open Access | Times Cited: 4
PD-L1 deglycosylation promotes its nuclear translocation and accelerates DNA double-strand-break repair in cancer
Zhen Shu, Bhakti Dwivedi, Jeffrey M. Switchenko, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 4
Oxygen-delivery nanoparticles enhanced immunotherapy efficacy monitored by granzyme B PET imaging in malignant tumors
Xingyi Wang, Hanyi Fang, Wenzhu Hu, et al.
Journal of Nanobiotechnology (2025) Vol. 23, Iss. 1
Open Access
Amuc_1434 From Akkermansia muciniphila Enhances CD8+ T Cell‐Mediated Anti‐Tumor Immunity by Suppressing PD‐L1 in Colorectal Cancer
Jiahao Zhu, Shaolei Qin, Ruike Gu, et al.
The FASEB Journal (2025) Vol. 39, Iss. 8
Closed Access
Challenges and the Evolving Landscape of Assessing Blood-Based PD-L1 Expression as a Biomarker for Anti-PD-(L)1 Immunotherapy
Tao Wang, Desirée Denman, Silvia M. Bacot, et al.
Biomedicines (2022) Vol. 10, Iss. 5, pp. 1181-1181
Open Access | Times Cited: 16
PIWI-RNAs Small Noncoding RNAs with Smart Functions: Potential Theranostic Applications in Cancer
Simona Taverna, Anna Masucci, Giuseppe Cammarata
Cancers (2023) Vol. 15, Iss. 15, pp. 3912-3912
Open Access | Times Cited: 9
Regulation of Extracellular Vesicle-Mediated Immune Responses against Antigen-Specific Presentation
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2022) Vol. 10, Iss. 10, pp. 1691-1691
Open Access | Times Cited: 14
PD-L1, STAT3, IL6, and EGFR Immunoexpressions in High-Grade Osteosarcoma
Nayla Rahmadiani, Eviana Norahmawati, Agustina Tri Endharti, et al.
Advances in Orthopedics (2024) Vol. 2024, pp. 1-7
Open Access | Times Cited: 2
Influencing immunity: role of extracellular vesicles in tumor immune checkpoint dynamics
Ziyang Ye, Genpeng Li, Jianyong Lei
Experimental & Molecular Medicine (2024) Vol. 56, Iss. 11, pp. 2365-2381
Open Access | Times Cited: 2
Exosome-Derived Non-Coding RNAs in the Tumor Microenvironment of Colorectal Cancer: Possible Functions, Mechanisms and Clinical Applications
Xian Chen, Mengmeng Jia, Jing Ji, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 10
Immunosuppressive nanoparticles containing recombinant PD-L1 and methotrexate alleviate multi-organ inflammation
Eun‐Koung An, Wei Zhang, Hae‐Bin Park, et al.
Biomaterials (2023) Vol. 301, pp. 122233-122233
Closed Access | Times Cited: 5
Missing prognostic value of soluble PD-1, PD-L1 and PD-L2 in lung cancer patients undergoing chemotherapy – A CEPAC-TDM biomarker substudy
Kimberly Geiger, Markus Joerger, Max Roessler, et al.
Tumor Biology (2024) Vol. 46, Iss. s1, pp. S355-S367
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top